Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men in France and Canada

Next Previous
Trial Profile

On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men in France and Canada

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 29 Dec 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
  • Indications HIV infections
  • Focus Therapeutic Use
  • Acronyms ANRS IPERGAY PrEP; IPERGAY

    • Most Recent Events

    • 30 Oct 2021 Results (n=417) assessing the epidemiology and baseline char - acteristics associated with HHV8 infection among MSM in the ANRS IPERGAY Pre- exposure prophylaxis (PrEP) trial, presented at the 18th European AIDS Conference.
    • 19 Jul 2021 Results (n=247) from ANRS IPERGAY DBS substudy measuring TFV-DP and FTC-TP concentrations in dried blood spots collected at the last study visit of the ANRS IPERGAY study, published in the Journal of Antimicrobial Chemotherapy
    • 11 Dec 2020 Results of sub study assessing the prevalence and incidence of MG infection in MSM published in the Clinical Infectious Diseases
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top